Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 4,743 $ 4,455
Accounts receivable, net 5,726 4,354
Note receivable 1,450
Inventories 3,930 6,611
Prepaid expenses and other current assets 477 812
Total Current Assets 16,326 16,232
Fixed assets, net 158 230
Right-of-use assets, operating leases 78 120
Goodwill 405
Other assets 205 155
Total Assets 17,172 16,737
Current Liabilities    
Accounts payable 3,217 6,928
Accrued and other liabilities 1,631 2,085
Credit facility, net 1,944 1,741
Term loan, net 2,881
Operating lease liability 60 57
Total Current Liabilities 6,852 13,692
Non-current Liabilities    
Operating lease liability 21 67
Total Non-current Liabilities 21 67
Total Liabilities 6,873 13,759
Stockholders’ Equity    
Common Stock, $0.001 par value, 200,000,000 shares authorized, 1,755,139 & 729,026 shares issued and outstanding as of September 30, 2024, and December 31, 2023, respectively 2 1
Additional paid-in capital 330,290 324,319
Accumulated deficit (319,993) (321,342)
Total Stockholders’ Equity 10,299 2,978
Total Liabilities and Stockholders’ Equity $ 17,172 $ 16,737